Background/Aims: Rectal carcinoid tumors can be resected with endoscopy, and it is important to assess their prognostic factors. We evaluated the potential of Ki-67 expression as a prognostic factor in rectal carcinoid tumors. Methods: We retrospectively reviewed the medical records of 37 patients with rectal carcinoid tumors who got endoscopic resection from January 2001 to January 2011 at Inje University Seoul Paik Hospital. We analyzed their endoscopic and histologic findings, Ki-67 expression, clinical outcome, and prognosis. Results: The mean age (±SD) of the patients was 56.3±10.7 years, and the male : female ratio was 3.6：1. The mean tumor size was 0.5±0.4 cm, 33 patients showed grade 1 tumors (89.2%) and the average Ki-67 expression was 0.7±1.2%. Thirty five patients underwent endoscopic mucosal resection, and two required endoscopic submucosal dissection. Eight patients had positive margins after resection, but no cases of lymphovascular invasion were identified. The median follow-up duration was 21.4±25.4 months, and no recurrences were observed. Conclusions: In low grade rectal carcinoid tumors which are lack of central depression on colonoscopy, the expression of a molecular marker of malignant potential, Ki-67, was low. Therefore, endoscopic resection seemed to be a safe and effective treatment for these tumors. (Korean J Gastroenterol 2013;61:82-87) 
INTRODUCTION
Carcinoid tumors can occur in nearly any gastrointestinal (GI) tissue, and historically they have been reported most frequently in the appendix. However, the bronchus/lung (27.9%), ileum (14.9%) and rectum (13.6%) are now the most commonly reported sites. 1 Rectal carcinoid tumors account for 1.1-1.3% of all rectal tumors, their metastatic incidence is 3.9%, and compared to other tumors they are less invasive and less progressive. 2 Rectal carcinoid tumors are often incidentally diagnosed during screening lower endoscopy for colorectal cancer or other unrelated indications. 3 They are most commonly found in the mid-rectum and can have a wide range of sizes. Rectal carcinoid tumors that are less than 1 cm in diameter rarely metastasize (3-5%), and they can be managed with local endoscopic resection. [4] [5] [6] [7] If the carcinoid tumor is over 2 cm, a full oncologic resection should be performed. 2 The treatment of rectal carcinoid tumors between 1-2 cm in diameter is controversial. In these cases it is critical to assess prognostic factors such as World Health Ki-67, a marker of cellular proliferation, has recently been introduced as a promising prognostic factor for rectal carcinoid tumors. 8 In this study, we evaluated the role of Ki-67 expression as a prognostic factor and predictive biomarker in low grade rectal carcinoid tumors.
SUBJECTS AND METHODS

Patients
We conducted cross sectional study on human partic- thereafter to monitor for local recurrence.
Immunohistochemical staining
All rectal carcinoid tumor specimens were reviewed by one expert pathologist and classified based on WHO criteria (Table 1) . 9, 10 The tissue specimens were then stained for proliferative activity and Ki-67 expression ＜0.7% or ≥0.7%.
Analysis was performed with an independent samples t-test.
RESULTS
Patient characteristics and outcomes
The mean age of the patients was 56. presented in Table 2 .
Rectal carcinoid tumors had a smooth, round, mobile, submucosal, and nodular appearance. There were no tumors which showed central depression on colonoscopy (Fig. 1A) .
EUS was performed before definitive treatment in 19 patients, including 6 patients who have the tumor size ≥1 cm (Fig. 1B) . EUS findings typically showed a hypoechoic mass in the submucosal layer of the rectum. Through the work-up including abdominopelvic CT or EUS, no lymph node enlargement or distant metastasis were found in any patients.
Therefore, endoscopic excision was tried for these patients.
In regards to margin positivity after endoscopic resection, 29 patients (78.4%) had clear margins, and 8 patients (21.6%)
had tumor involvement at the resected margins. In patient who showed tumor involvement at the resected margins, short-term follow-up (within 3 months) was done and revealed no residual tumors in all cases. Endoscopic examinations were performed periodically to monitor for local recurrence during the follow-up period. The median follow-up duration was 21.4±25.4 months (range 0-87 months). Six patients were followed up by more than 3 years, and no recurrences were identified.
Ki-67 expression
The average Ki-67 expression was 0.7±1.2% (Fig. 2) .
Subgroups of Ki-67 expression based on tumor size, patient age, gender, and margin positivity are presented in Table 3 . In regards to tumor grading by WHO criteria, 33 patients had grade 1 tumors, and four patients had grade 2 tumors.
In aspect of mitosis, no mitosis was seen in all cases. Tumor size, patient age, gender, and margin positivity were not related to tumor grade (Table 4) .
When rectal carcinoid tumor specimens were divided into two groups based on mean value of Ki-67 expression, that was ＜0.7% or ≥0.7%, there was no correlation between Ki-67 expression and tumor size, patient age, gender, or margin positivity (Table 5) .
DISCUSSION
GI carcinoid tumors arise from subepithelial neuroendocrine cells, penetrate the muscularis mucosa, and invade the submucosal layer at an early stage. Therefore, they appear as submucosal lesions on endoscopic finding. Since the widespread implementation of colorectal cancer screening, GI carcinoid tumors have begun to be discovered at an early stage. 12 Well-differentiated, grade 1 carcinoid tumors less than 10 mm in diameter that are confined to the submucosal layer can be treated with endoscopic resection. A variety of endoscopic techniques are used, including conventional polypectomy, band-snare resection, cap-assisted EMR and ESD. [13] [14] [15] Previous reports have shown that ESD results in a higher proportion of histologically complete resections with a similar complication rate to EMR. 16, 17 In our study, most patients received EMR as treatment for their rectal carcinoid tumor; only two patients underwent ESD.
EUS has a high sensitivity (87%) in the diagnosis of rectal carcinoid tumors, which are usually well-demarcated isoechoic or hypoechoic masses. 13 The main applications of EUS in rectal carcinoid tumors are for the evaluation of tumor size, depth of invasion, and perirectal lymphadenopathy. 18 In our study, EUS was performed in 19 patients, and all tumors were confined to the submucosa without invasion of the muscularis propria. Especially, in 6 patients who had tumor sized ≥1 cm, EUS revealed that tumor was confined to the submucosa.
In this study, we evaluated the role of Ki-67 expression as a prognostic factor in low grade rectal carcinoid tumors. Ki-67 expression is widely used as a marker of proliferation in various types of tumors. [19] [20] [21] However, the role of Ki-67 expression as a prognostic factor in rectal carcinoid tumors has not been fully established. The mean tumor size in our study was 0.52 cm, and most tumors had grade 1 histology. Therefore, low grade rectal carcinoid tumors and low Ki-67 expression suggested a good prognosis. We conclude that endoscopic resection is an effective therapeutic strategy for low grade rectal carcinoid tumors. EUS might be helpful to be performed prior to resection. If the tumor is less than 10 mm, without a central depression, with invasion restricted to the mid-submucosa, and no lymph node involvement or distant metastasis, endoscopic resection is indicated.
Our study has several limitations. The number of sample size was small, and all data were retrospectively reviewed.
There were no comparable control groups, and all enrolled patients had non-metastatic, non-invasive tumors. These compositions of our study population may have contributed to the overall low levels of Ki-67 expression. The follow-up period of 10 years (with a median follow-up duration of 21.4±25.4 months) was relatively short.
Our study showed that Ki-67 expression was low in low grade rectal carcinoid tumors which are lack of central depression on colonoscopy. Therefore, we suggest that endoscopic resection seemed to be a safe and effective treatment for these tumors.
